Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baxdrostat on Ventricular Remodeling
NCT07655362Phase 3Not yet recruiting
- Start
- Jun 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 3 trial of baxdrostat in cardiac remodeling, hypertension (HTN). Planned start Jun 2026; status: not yet recruiting.
02
Drugs
baxdrostat
03
Conditions
cardiac remodelinghypertension (HTN)
Beyond the preview
Go deeper on NCT07655362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07655362.